Human extracellular matrices can be edited in their composition using the CRISPR/Cas9 system, leading to materials exhibiting tailored regenerative capacities.

Case Study Highlights INDIBA 448 kHz Radiofrequency's Role in Visceral Fat Reduction and Prevention of Fat Accumulation ...

INmune Bio Inc. (NASDAQ: INMB) (the "Company"), a clinical-stage inflammation and immunology company focused on developing treatments that harness ...

Final overall survival results show amivantamab plus lazertinib beat out osimertinib for first-line treatment of advanced ...

A new high-level scientific Advisory Board has been established to accompany and support the research, clinical, and ...

Conduit Pharmaceuticals reports advancements in lupus studies and trial designs. The Company partnered with Charles River ...